Highlights
ASX: CYC       CYCLOPHARM LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.21   -0.05 (3.97%)  1.21 - 1.26  2,295

Overview

 
Avg Volume (4 weeks):8,197
4 Weeks Range:1.05 - 1.30
4 Weeks Price Volatility (%):
64.00%
52 Weeks Range:0.965 - 1.505
52 Weeks Price Volatility (%):
45.37%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cyclopharm Limited is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. The Company operates in two business segments: Technegas segment and Molecular imaging segment. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals used by physicians in the detection of cancer, neurological disorders and cardiac diseases. The Company offers Technegas for lung imaging, and Molecular Imaging/Positron Emission Tomography radiopharmaceuticals, which are used in cancer, brain and cardiac imaging. The Company formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Company's Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.

  Be the first to like this.
 


 

486  622  827  2437 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GTG 0.006+0.001 
 MEB 0.011-0.002 
 SCG 3.85-0.02 
 SIQ 11.25-0.85 
 CL8 0.014+0.005 
 NVO 0.0150.00 
 SRO 0.0020.00 
 MLX 0.185+0.01 
 88E 0.0140.00 
 AUZ 0.029+0.002 
Partners & Brokers